Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-02-01 @ 7:55 PM
Study NCT ID:
NCT07008703
Status:
RECRUITING
Last Update Posted:
2025-06-06
First Post:
2024-01-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain
Sponsor:
Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer Pain | View |
Keywords: